Nexgen Pharma Inc Company Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the competitive landscape for NEXGEN PHARMA INC, and what generic and branded alternatives to NEXGEN PHARMA INC drugs are available?
NEXGEN PHARMA INC has thirteen approved drugs.
Drugs and US Patents for Nexgen Pharma Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nexgen Pharma Inc | PHENDIMETRAZINE TARTRATE | phendimetrazine tartrate | TABLET;ORAL | 086020-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Nexgen Pharma Inc | DIMENHYDRINATE | dimenhydrinate | TABLET;ORAL | 085985-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Nexgen Pharma Inc | PROPOXYPHENE HYDROCHLORIDE | propoxyphene hydrochloride | CAPSULE;ORAL | 083185-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Nexgen Pharma Inc | MECLIZINE HYDROCHLORIDE | meclizine hydrochloride | TABLET, CHEWABLE;ORAL | 086392-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Nexgen Pharma Inc | SODIUM PENTOBARBITAL | pentobarbital sodium | TABLET;ORAL | 084238-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Nexgen Pharma Inc | MEPROBAMATE | meprobamate | TABLET;ORAL | 084589-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.